← Back to Search

Multimodal analgesia including pregabalin for Postoperative Pain

Phase 4
Waitlist Available
Led By Jonathan Danoff, MD
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours
Awards & highlights

Study Summary

This trial is examining whether sex affects postoperative pain following knee surgery, and whether different pain relief regimens make a difference.

Eligible Conditions
  • Postoperative Pain
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess influence of sex and multimodal analgesia regimens on acute postoperative pain scores at 48 hours postoperatively, in patients undergoing TKA.
Secondary outcome measures
Assess how sex differences and multimodal analgesia regimens influence chronic postoperative pain
Assess how sex differences and multimodal analgesia regimens influence mental health
Assess how sex differences and multimodal analgesia regimens influence physical function
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multimodal analgesia regimen including pregabalinExperimental Treatment1 Intervention
For the pregabalin group, patient will be provided with an oral preoperative pregabalin dose of 150mg on the day of surgery. Patient will continue pregabalin 75mg two times a day, for two weeks postoperatively. For both the intervention and control groups, the operative technique and additional perioperative analgesic modalities will follow a standard protocol
Group II: Multimodal analgesia regimen not including pregabalinActive Control1 Intervention
For the non-pregabalin group, patient will be undergo total knee arthroplasty with the same operative technique and additional perioperative analgesic modalities will follow a standard protocol

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
458 Previous Clinical Trials
470,683 Total Patients Enrolled
4 Trials studying Postoperative Pain
372 Patients Enrolled for Postoperative Pain
Jonathan Danoff, MDPrincipal InvestigatorNorthwell Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I qualified to partake in this investigation?

"This clinical trial will accept 300 participants, aged between 18 and 80, who suffer from chronic pain. Additionally, potential patients must reside in a private home rather than an institution or rehabilitation centre; express consent to comply with the study's regulations; and remain available for its entirety."

Answered by AI

Has the FDA sanctioned Multimodal analgesia with pregabalin?

"Our safety rating of Multimodal analgesia including pregabalin is a 3, due to Phase 4 data confirming its approval."

Answered by AI

How many people have been recruited to participate in this experiment?

"Affirmative. Clinicaltrials.gov data demonstrate that this particular medical trial is actively recruiting participants, having first been posted on December 9th 2020 and last updated on July 15th 2022. It requires 300 people from a single site to take part in the study."

Answered by AI

Is the age range of participants in this study limited to individuals under 35 years old?

"This trial is accepting individuals who are within the age range of 18 to 80 years."

Answered by AI

Is this experiment seeking new participants at the present time?

"Clinicaltrials.gov provides evidence that this research project, which was first posted in December 2020 and most recently edited on July 15th 2022, is actively searching for suitable patients."

Answered by AI
~58 spots leftby Apr 2025